Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Buckley Capital 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Buckley Capital)

Primary Source Intelligence • Q1 2024 Letter Analysis

Buckley Capital Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Buckley Capital. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+13.4%

Digest Analysis

Quick Take

"The manager initiated Ingevity at 7-8x normalized earnings and doubled Chemours on temporary weakness."

Executive Summary

Buckley Capital delivered 4.08% net returns in Q1 2024, outperforming small-cap benchmarks. The manager remains very bullish on small caps given the strong economy and potential for lower interest rates, noting that the valuation differential between small and large caps is extremely attractive at the 7th percentile since 1930. Key portfolio moves included initiating a position in specialty chemicals company Ingevity at attractive valuations following temporary margin pressure, and doubling the Chemours position after a 45% decline on delayed filing concerns. The fund exited Griffon and Goeasy positions to redeploy capital into higher-conviction opportunities. IWG remains the second-largest position, benefiting from commercial real estate disruption as it transitions to a capital-light co-working model. The manager expects significant upside from current positioning, particularly as specialty chemical end markets rebound and crude tall oil costs normalize. Portfolio concentration in undervalued small-cap names positions the fund well for the anticipated small-cap outperformance cycle.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

78%

CautiousHigh

High Conviction (78%)

High conviction evidenced by concentrated portfolio with named, sized positions including 'second largest position' in IWG. Manager provides specific earnings estimates for NGVT ($5-6 in 2025) and detailed multi-year return projections. Willingness to double down on Chemours during weakness and specific IRR thresholds for buying (30%+) and selling (20%) demonstrate strong conviction in investment process.

Growth Outlook

75%

BearishBullish

Bullish (75%)

Manager is explicitly very bullish on small caps, stating the economy is very strong and interest rates should be coming down. Uses language like 'sets up small-cap stocks to perform very well' and 'we should benefit significantly in this kind of environment.'

Risk Appetite

60%

DefensiveAggressive

Balanced (60%)

Portfolio shows active risk-taking with new position initiation and doubling down on Chemours during weakness. However, also shows discipline by exiting positions when risk/reward becomes unfavorable, indicating selective rather than maximum risk appetite.

Capital Deployment

45%

De-riskingDeploying

Net Neutral (45%)

Mixed deployment activity with new position initiation in NGVT and doubling of Chemours position, but offset by complete exits of Griffon and Goeasy. Net effect appears to be capital rotation rather than significant new deployment, as proceeds from sales funded new purchases.

Forward Guidance

65%

CautiousExpansionary

Expansionary (65%)

Manager is actively deploying capital into new positions like NGVT and scaling existing positions like Chemours. Expresses excitement about fund prospects in 2024 and anticipates significant upside from current positioning.

Language Signal

70%

BearishBullish

Bullish (70%)

Language is predominantly bullish with terms like 'very bullish,' 'extremely attractive,' 'dramatic upside,' and 'excited about prospects.' Risk language is present but balanced with opportunity framing.

Perceived Risk

35%

Low RiskElevated

Moderate Risk (35%)

Manager acknowledges some risks including economic sensitivity for IWG and regulatory concerns for Goeasy, but these are mentioned briefly and not central to the letter. Focus is primarily on opportunities rather than risks, with confident tone throughout.

Opportunity Density

75%

ScarceAbundant

Abundant (75%)

Manager sees abundant opportunities in small caps, describing valuations as 'extremely attractive' at 7th percentile levels. Identifies specific opportunities across specialty chemicals and commercial real estate, with detailed analysis of multiple attractive investments.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Manager discusses multi-year thesis realization with specific timeframes: 12-18 months for Ingevity recovery, 3-5 year multi-bagger potential, and 5-year projections for IWG. Uses IRR framework suggesting medium-term investment horizon rather than permanent capital approach.